Why the study?
Does aging affect the number of platelet prostacyclin (PGI2) receptors in healthy humans?
Does aging affect the number of platelet prostacyclin (PGI2) receptors in healthy humans?
The number of high and low affinity platelet prostacyclin receptors decreases significantly with age in healthy humans, which may influence age-related changes in platelet reactivity.
May contribute to age-related platelet hyperreactivity; hypothesis-generating and requires longitudinal confirmation.
Platelet receptors for PGI2 were investigated in eighteen healthy volunteers divided in two classes of age: nine were 18-40 years old and nine were 41-65 years old. PGI2 platelet receptors were found to decrease significantly with age; the young subjects had 106 +/- 16 (mean +/- SD) high affinity receptors/platelet and 3509 +/- 529 low affinity receptors/platelet whereas the old subjects had 86 +/- 14 high affinity receptors/platelet (P less than 0.02) and 2471 +/- 640 low affinity receptors/platelet (P less than 0.005). The cumulated data from all the subjects yielded a significant negative correlation with age (r = -0.71, P less than 0.001 for the high affinity class and r = -0.65, P less than 0.01 for the low affinity class). The affinity of receptor sites for the ligand did not statistically change with aging (P less than 0.30 and P less than 0.90 respectively for high and low affinity receptors).
No takes yet. Share an insight, caveat, or question.
Modesti et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: